Based on typical FDA review timelines and the current progress of trials, analysts project: Phase 3 trial completion: Late 2025 to early 2026 FDA submission: First half of 2026 Potential FDA approval: Q3 2026 to Q1 2027 Commercial availability: 2-3 months post-approval The FDA has not granted any special designations (Breakthrough Therapy, Fast Track) for Retatrutides obesity indication, which may mean standard review timelines apply
Serious allergic reactions (anaphylaxis) Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and a very rapid heartbeat
Following your final injection, semaglutide doesnt immediately disappear
If the medication is not stored correctly, it may not last as long as the expiration date suggests
Light protection Semaglutide is sensitive to light exposure
GUO: But now, he says, he was finally able to be the guy he wanted to be for himself, for his kid, for his wife